Business Context and Reporting Period
Company: Coca-Cola Europacific Partners Plc (CCEP)
Filing Type: Form 6-K (Report of Foreign Private Issuer)
Reporting Period: July 16, 2025 to July 22, 2025
Business Overview: CCEP is a leading consumer goods company operating across 31 countries, serving nearly 600 million consumers and over 4 million customers. The company is listed on Euronext Amsterdam, NASDAQ, the London Stock Exchange, and Spanish Stock Exchanges.
Key Financial Metrics and Transactions
This filing details ongoing share repurchase activities under a program announced on February 14, 2025, with an aggregate authorization of up to EUR 1 billion. All repurchased shares are cancelled.
| Date of Purchase | US Venues (Shares) | US VWAP (USD) | London Venues (Shares) | London VWAP (GBP) |
|---|---|---|---|---|
| July 15, 2025 | 37,601 | $94.05 | 16,450 | £70.81 |
| July 16, 2025 | 37,451 | $94.42 | 15,330 | £70.19 |
| July 17, 2025 | 36,986 | $95.61 | 16,652 | £71.24 |
| July 18, 2025 | 36,417 | $97.10 | 15,206 | £72.03 |
| July 21, 2025 | 36,269 | $97.50 | 14,813 | £72.23 |
Total Shares Repurchased (Period): Approximately 181,724 shares on US venues and 78,451 shares on London venues.
Financial Metrics: The filing does not provide revenue, profit, cash flow, margins, debt, or liquidity figures. It focuses exclusively on capital allocation via share buybacks.
Material Changes
Share Price Trend: During the reporting period, the volume-weighted average price (VWAP) for repurchases increased on both US and London venues.
- US Venues: VWAP rose from $94.05 on July 15 to $97.50 on July 21.
- London Venues: VWAP rose from £70.81 on July 15 to £72.23 on July 21.
Program Status: The company continues to execute its EUR 1 billion buyback program. No material changes to the program's authorization or strategy were announced in this filing.
Guidance, Outlook, and Risks
Management Commentary: The filing confirms that purchases are part of the ongoing share buyback program. No new guidance, outlook, or strategic commentary was provided beyond the execution of the program.
Risks and Contingencies: The filing states that the announcements do not constitute an offer or solicitation of securities. It references compliance with the Market Abuse Regulation (EU) No 596/2014 as applied in the UK.
Unusual Items: None reported. Transactions were executed via Goldman Sachs & Co. LLC and affiliates.
Investor Verification Checklist
- Program Remaining Capacity: Verify the total amount spent to date against the EUR 1 billion authorization to determine remaining buyback capacity.
- Share Count Impact: Confirm the reduction in total outstanding shares following the cancellation of the repurchased shares.
- Market Price Correlation: Compare the VWAP paid during this period against the closing market prices to assess execution efficiency.
- Regulatory Compliance: Review the linked RNS schedules for full transaction details as required by the Market Abuse Regulation.